RGC Stock Price | Regencell Bioscience Holdings Ltd P/E, Revenue, EPS, & Forecasts

Regencell Bioscience Holdings Ltd • RGC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Regencell Bioscience Holdings Ltd

Ticker

RGC

Trading on

NASDAQ

ISIN

KYG7487R1002

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

CEO

Yat-Gai Au

Headquarters

Chinachem Leighton Plaza, Causeway Bay, undefined, Hong Kong, undefined

Employees

Website

regencellbioscience.com

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Metrics

BasicAdvanced

Market cap

$6.44B

P/E ratio

EPS

-$0.01

Dividend Yield

0.00%

Beta

Forward P/E ratio

EBIDTA

$-3.7M

Ex dividend date

Price & volume

Market cap

$6.44B

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

1,189.21

Earnings

EPS

-$0.01

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-3.7M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

52-week High

$83.60

52-week Low

$0.09

50-day moving average

$15.55

200-day moving average

$10.75

Short ratio

5.89

Short %

1.47%

Management effectiveness

ROE (TTM)

-54.81%

ROA (TTM)

-33.20%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

494M

Float

18.4M

Insiders %

88.56%

Institutions %

0.14%

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.01

Q2 • 19Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$-0.9M

0.00%

Q3 • 24

$-1.9M

0.00%

Q4 • 24

NaN%

100.00%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$7.5M

$0.8M

10.21%

Q3 • 24

$7.5M

$0.8M

10.21%

Q4 • 24

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

Q3 • 24

Q4 • 24

NaN%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Regencell Bioscience Holdings Ltd share?

Regencell Bioscience Holdings Ltd shares are currently traded for undefined per share.

How many shares does Regencell Bioscience Holdings Ltd have?

Regencell Bioscience Holdings Ltd currently has 494M shares.

Does Regencell Bioscience Holdings Ltd pay dividends?

No, Regencell Bioscience Holdings Ltd doesn't pay dividends.

What is Regencell Bioscience Holdings Ltd 52 week high?

Regencell Bioscience Holdings Ltd 52 week high is $83.60.

What is Regencell Bioscience Holdings Ltd 52 week low?

Regencell Bioscience Holdings Ltd 52 week low is $0.09.

What is the 200-day moving average of Regencell Bioscience Holdings Ltd?

Regencell Bioscience Holdings Ltd 200-day moving average is $10.75.

Who is Regencell Bioscience Holdings Ltd CEO?

The CEO of Regencell Bioscience Holdings Ltd is Yat-Gai Au.

How many employees Regencell Bioscience Holdings Ltd has?

Regencell Bioscience Holdings Ltd has 12 employees.

What is the market cap of Regencell Bioscience Holdings Ltd?

The market cap of Regencell Bioscience Holdings Ltd is $6.44B.

What is the P/E of Regencell Bioscience Holdings Ltd?

The current P/E of Regencell Bioscience Holdings Ltd is null.

What is the EPS of Regencell Bioscience Holdings Ltd?

The EPS of Regencell Bioscience Holdings Ltd is -$0.01.

What is the PEG Ratio of Regencell Bioscience Holdings Ltd?

The PEG Ratio of Regencell Bioscience Holdings Ltd is null.